With a valuation of <b>4.5 billion USD</b> in 2023, the <b>Methylphenidate For ADHD Treatment Market</b> is expected to reach <b>7.2 billion USD </b> by 2033, growing at a CAGR of <b>4.8%</b> from 2024 onwards. The report encompasses various segments and analyzes the trends and factors significantly impacting the market.
